What if the meeting is to also close the loop on Breakthrough Designation. Just sayin......again....
- Forums
- ASX - By Stock
- NEU
- Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.5%
!
$13.86

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.86 |
Change
1.320(10.5%) |
Mkt cap ! $1.728B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $6.028M | 443.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 258 | $13.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.86 | 249 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 389 | 13.840 |
2 | 139 | 13.830 |
1 | 105 | 13.820 |
4 | 633 | 13.810 |
1 | 75 | 13.800 |
Price($) | Vol. | No. |
---|---|---|
13.850 | 547 | 1 |
13.860 | 415 | 7 |
13.870 | 165 | 2 |
13.880 | 382 | 3 |
13.890 | 654 | 4 |
Last trade - 11.11am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online